LS9, Inc., the Renewable Petroleum Company, an industrial biotechnology company pursuing the commercial development of renewable fuels and chemicals, completed a $25m round of funding.
Participating investors in the round included CTTV Investments LLC, the venture capital arm of Chevron Technology Ventures LLC, Flagship Ventures, Khosla Ventures and Lightspeed Venture Partners.
LS9, founded in 2005, is applying synthetic biology to produce proprietary biofuels that are compatible with existing fuel distribution and consumer infrastructure, as well as high-value industrial chemicals.
Stephen del Cardayre, Vice President, Research and Development of South San Francisco, CA.-based LS9, said: “LS9 represents one of the cleanest and most efficient technologies available in the production of high-value, low-carbon, cost effective fuels, and this funding will accelerate our ability to demonstrate commercial level production”.
FinSMEs
25/09/2009